Aesica Expands Oral Solids Capability at German Facility - - BioPharm International

ADVERTISEMENT

Aesica Expands Oral Solids Capability at German Facility



Aesica Pharmaceuticals, a CDMO, is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany.

The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.

Source: Aesica Pharmaceuticals

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Author Guidelines

Click here